Seeing Is Believing
Currently out of the existing stock ratings of Michael Schmitz, 18 are a BUY (81.82%), 4 are a HOLD (18.18%).
Analyst Michael Schmitz, carries an average stock price target met ratio of 43.75% that have a potential upside of 44.9% achieved within 425 days. Previously, Michael Schmitz worked at LADENBURG.
Michael Schmitz’s has documented 39 price targets and ratings displayed on 9 stocks. The coverage was on Energy, Healthcare sectors.
Most recent stock forecast was given on RVMD, Revolution Medicines at 28-Oct-2024.
Analyst best performing recommendations are on OAS (OASIS PETROLEUM).
The best stock recommendation documented was for OAS (OASIS PETROLEUM) at 7/13/2016. The price target of $12 was fulfilled within 119 days with a profit of $3.13 (35.29%) receiving and performance score of 2.97.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$74.28
$0.01 (0.01%)
$75
2 years 4 months 15 days ago
(24-Oct-2022)
5/8 (62.5%)
$0.38 (0.51%)
110
Hold
$74
$-0.27 (-0.36%)
$72
2 years 4 months 15 days ago
(24-Oct-2022)
9/9 (100%)
$0.1 (0.14%)
48
Sell
$74
$-0.27 (-0.36%)
$67
2 years 4 months 20 days ago
(19-Oct-2022)
8/10 (80%)
$0.43 (0.58%)
21
Sell
$74
$-0.27 (-0.36%)
$70
2 years 4 months 21 days ago
(18-Oct-2022)
9/11 (81.82%)
$0.32 (0.43%)
23
Sell
$70
$-4.27 (-5.75%)
$73
2 years 6 months 8 days ago
(31-Aug-2022)
10/17 (58.82%)
$0.17 (0.24%)
250
Which stock is Michael Schmitz is most bullish on?
Which stock is Michael Schmitz is most reserved on?
What Year was the first public recommendation made by Michael Schmitz?